Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2021-12-13 AGM Information
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Compte-rendu de l'Assemblée Générale ordinaire du 10 décembre 2021
AGM Information Classification · 1% confidence The document is explicitly titled "Compte-rendu de l'Assemblée Générale ordinaire du 10 décembre 2021" (Minutes/Report of the Ordinary General Meeting of December 10, 2021). It details the proceedings, quorum, and the results of votes on resolutions concerning the appointment of directors. This content directly relates to the outcomes and records of a General Meeting. The most appropriate classification is AGM-R (AGM Information), as it reports on the meeting's activities and results, which is often included in or immediately follows the AGM materials.
2021-12-13 French
Mise à jour des prévisions 2021
Earnings Release Classification · 1% confidence The document is a press release dated December 6, 2021, providing an update on the 2021 financial outlook and setting financial perspectives for 2022 (Revenue > 350 M€, EBITDA ratio >= 8%). It discusses revenue forecasts, EBITDA impacts due to energy costs, and medium-term EBITDA targets. This content structure—providing updated guidance and outlook rather than full historical financial statements (like 10-K or IR) or a transcript of a call—is characteristic of an Earnings Release (ER) or a preliminary update preceding a full report. Since it provides key financial highlights and forward-looking statements immediately following the period end (or near it), it fits the definition of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR). The mention of the AGM on Dec 10, 2021, is a future event reference, not the primary content of this update. FY 2021
2021-12-06 French
METabolic EXplorer announces the second process resulting from its ALTANØØVTM platform for the production of L-Valine.
Earnings Release Classification · 1% confidence The document is a press release dated December 1, 2021, announcing a technological development (a new process for L-Valine production via the ALTANØØVTM platform) and its implications for animal nutrition. It details scientific progress, market context, and future regulatory steps (EFSA application). This type of announcement, focusing on operational and strategic updates rather than comprehensive periodic financial results (like a 10-K or IR), is characteristic of a general corporate announcement or press release. Since it is not a formal regulatory filing like a 10-K, a specific financial report (IR), or a management discussion (MDA), and it is not a transcript (CT) or a dividend notice (DIV), it fits best under the general 'Regulatory Filings' (RNS) category as a significant corporate update that is typically disseminated via regulatory news services, or potentially an Earnings Release (ER) if it were tied to a specific reporting period, but here it is purely operational/R&D focused. Given the options, RNS serves as the best fit for a non-standard, material corporate announcement that isn't explicitly defined elsewhere. H1 2022
2021-12-01 English
METabolic EXplorer annonce le second procédé issu de sa plateforme ALTANØØVTM pour la production de L-Valine.
Regulatory Filings Classification · 1% confidence The document is a press release dated December 1, 2021, announcing a technological development (a second process for L-Valine production) and its implications for the company's commercial offering and regulatory path. It contains key highlights, strategic commentary from the CEO, and forward-looking statements regarding regulatory approval timelines. This structure is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it is not a full annual report (10-K), a detailed interim report (IR), a transcript (CT), or a specific regulatory filing like a Director's Dealing (DIRS) or Proxy Statement (PSI), and it focuses on operational and product news rather than just financial figures, it best fits the 'Earnings Release' category, which often includes operational updates alongside financial context, or potentially a Regulatory Filing (RNS) if it were less detailed. Given the announcement nature of a new process and its market impact, ER is a strong candidate, but since it is not explicitly labeled as a quarterly or half-year financial results announcement, and it is a general corporate update, it leans towards a general announcement. However, in the context of financial reporting, major operational announcements that impact future performance are often grouped with ERs or treated as Regulatory Filings (RNS). Since it is a formal announcement of a significant business development, and not a request for a vote or a report publication notice, I will classify it as a Regulatory Filing (RNS) as a broad category for significant, non-standard announcements, or ER if it's considered a major operational update preceding formal results. Given the content is a strategic business update rather than a summary of period financial results, RNS is the safer fallback for a significant, non-standard announcement, but ER often covers major operational news. Let's re-evaluate: It announces a new process and its competitive advantage. This is a significant corporate event announcement. If it were purely financial results, it would be ER. Since it's a strategic/operational announcement, RNS is appropriate as a general regulatory announcement, or potentially IP if it were a presentation. Given the options, RNS covers general corporate news that doesn't fit elsewhere well. However, many companies issue operational updates alongside or instead of formal ERs. Since it is a formal announcement of a business milestone, I will lean towards RNS as the most appropriate general regulatory announcement category when ER is reserved strictly for period results summaries.
2021-12-01 French
Assemblée Générale Ordinaire du 10 décembre 2021 - Modalités de mise à disposition des documents préparatoires
AGM Information Classification · 1% confidence The document is titled "Assemblée Générale Ordinaire du 10 décembre 2021 Modalités de mise à disposition des documents préparatoires" (Ordinary General Meeting of December 10, 2021 Modalities for making preparatory documents available). It explicitly discusses the convocation of shareholders for an Ordinary General Meeting (AGM) on a specific date (December 10, 2021) and lists the agenda items (resolutions). Although it announces the availability of preparatory documents, the core subject matter is the AGM itself, including logistics and voting procedures. This aligns best with the 'AGM Information' category (AGM-R), which covers presentations and materials shared during the AGM, or potentially PSI if it were purely a proxy statement, but the direct reference to the meeting details makes AGM-R the most precise fit for the event announcement.
2021-11-19 French
METabolic EXplorer : Point sur l'activité de METEX NØØVISTA.
Earnings Release Classification · 1% confidence The document is a press release dated November 16, 2021, providing an update on the operational status of the subsidiary METEX NØØVISTA, specifically mentioning the successful restart of PDO production and the first sales of AB. It details operational milestones and includes quotes from management. This type of communication, focusing on recent operational achievements and business highlights outside of a formal quarterly or annual filing structure, is characteristic of an Earnings Release (ER) or a general operational update. Since it focuses on key operational achievements and initial sales rather than a comprehensive financial statement (like an IR or 10-K), 'ER' (Earnings Release) is the most appropriate classification, as these releases often precede or summarize the formal financial reporting period. FY 2021
2021-11-16 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.